Insider · CIK 0001614096

Ives Jeffrey L.

Reports to the SEC for 2 companies · NEWTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001614096

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-03	ABOSAcumen Pharmaceuticals, Inc.A Award	Director	AAward	+35.5K sh	—	—	48,300
2026-06-03	ABOSAcumen Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+53.3K sh	—	—	53,250
2025-06-04	ABOSAcumen Pharmaceuticals, Inc.A Award	Director	AAward	+12.8K sh	—	—	12,800
2025-06-04	ABOSAcumen Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+19.5K sh	—	—	19,500
2024-06-10	ABOSAcumen Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2024-06-04	TVRDTvardi Therapeutics, Inc.A Award	Director	AAward	+151K sh	—	—	198,485
2024-06-04	TVRDTvardi Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+195K sh	—	—	195,000
2023-08-17	ABOSAcumen Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+39.1K sh	$0.72	+$28.2K	39,149
2023-08-17	ABOSAcumen Pharmaceuticals, Inc.S Sale	Director	SSale	−39.1K sh	$6.48	−$254K	0
2023-08-17	ABOSAcumen Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,800 sh	$1.19	+$3,332	2,800
2023-08-17	ABOSAcumen Pharmaceuticals, Inc.S Sale	Director	SSale	−2,800 sh	$6.66	−$18.6K	0
2023-08-17	ABOSAcumen Pharmaceuticals, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−39.1K sh	—	—	0
2023-08-17	ABOSAcumen Pharmaceuticals, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,800 sh	—	—	0
2023-06-06	ABOSAcumen Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2023-06-01	TVRDTvardi Therapeutics, Inc.A Award	Director	AAward	+32.4K sh	—	—	47,838
2023-06-01	TVRDTvardi Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+45K sh	—	—	44,961
2022-07-15	TVRDTvardi Therapeutics, Inc.S Sale	Director	SSale	−3,600 sh	$9.05	−$32.6K	15,476
2022-06-15	ABOSAcumen Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2022-06-02	TVRDTvardi Therapeutics, Inc.A Award	Director	AAward	+11.9K sh	—	—	19,076
2022-06-02	TVRDTvardi Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17K sh	—	—	16,996
2021-11-12	TVRDTvardi Therapeutics, Inc.S Sale	Director	SSale	−8,180 sh	$16.04	−$131K	7,200
2021-06-30	ABOSAcumen Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+34K sh	—	—	34,000
2021-06-07	TVRDTvardi Therapeutics, Inc.S Sale	Director	SSale	−2,520 sh	$13.05	−$32.9K	15,380
2021-06-03	TVRDTvardi Therapeutics, Inc.A Award	Director	AAward	+7,200 sh	—	—	17,900
2021-06-03	TVRDTvardi Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10.8K sh	—	—	10,800
2020-11-19	TVRDTvardi Therapeutics, Inc.A Award	Director	AAward	+2,500 sh	$15.75	+$39.4K	10,700
2020-11-19	TVRDTvardi Therapeutics, Inc.S Sale	Director	SSale	−2,500 sh	$15.75	−$39.4K	10,700
2020-06-04	TVRDTvardi Therapeutics, Inc.A Award	Director	AAward	+7,200 sh	—	—	13,200
2020-06-04	TVRDTvardi Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10.8K sh	—	—	10,800
2020-06-01	TVRDTvardi Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,000 sh	$9.94	+$9,940	7,000
2020-06-01	TVRDTvardi Therapeutics, Inc.S Sale	Director	SSale	−1,000 sh	$16.00	−$16K	6,000
2020-06-01	TVRDTvardi Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,000 sh	—	—	0
2020-05-12	TVRDTvardi Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,500 sh	$9.94	+$24.9K	8,500
2020-05-12	TVRDTvardi Therapeutics, Inc.S Sale	Director	SSale	−2,500 sh	$16.00	−$40K	6,000
2020-05-12	TVRDTvardi Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,500 sh	—	—	1,000
2020-04-21	TVRDTvardi Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,500 sh	$9.94	+$24.9K	8,500
2020-04-21	TVRDTvardi Therapeutics, Inc.S Sale	Director	SSale	−2,500 sh	$16.00	−$40K	6,000
2020-04-21	TVRDTvardi Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,500 sh	—	—	3,500
2020-03-04	TVRDTvardi Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,500 sh	$9.94	+$24.9K	8,500
2020-03-04	TVRDTvardi Therapeutics, Inc.S Sale	Director	SSale	−2,500 sh	$16.00	−$40K	6,000
2020-03-04	TVRDTvardi Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,500 sh	—	—	6,000
2020-02-03	TVRDTvardi Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,500 sh	$9.94	+$24.9K	8,500
2020-02-03	TVRDTvardi Therapeutics, Inc.S Sale	Director	SSale	−2,500 sh	$16.23	−$40.6K	6,000
2020-02-03	TVRDTvardi Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,500 sh	—	—	8,500
2020-01-02	TVRDTvardi Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,500 sh	$9.94	+$24.9K	8,500
2020-01-02	TVRDTvardi Therapeutics, Inc.S Sale	Director	SSale	−2,500 sh	$16.13	−$40.3K	6,000
2020-01-02	TVRDTvardi Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,500 sh	—	—	11,000
2019-12-02	TVRDTvardi Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,500 sh	$5.32	+$13.3K	8,500
2019-12-02	TVRDTvardi Therapeutics, Inc.S Sale	Director	SSale	−2,500 sh	$25.83	−$64.6K	6,000
2019-12-02	TVRDTvardi Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,500 sh	—	—	0

Recent filings

Accepted (ET)
Jun 54
Ives Jeffrey L.0001628280-26-041270
SEC(opens sec.gov)
Jun 54
Ives Jeffrey L.0001576885-25-000079
SEC(opens sec.gov)
Jun 104
Ives Jeffrey L.0001576885-24-000086
SEC(opens sec.gov)
Jun 64
Ives Jeffrey L.0001415889-24-015760
SEC(opens sec.gov)
Aug 184
Ives Jeffrey L.0001576885-23-000052
SEC(opens sec.gov)
Jun 74
Ives Jeffrey L.0001576885-23-000034
SEC(opens sec.gov)
Jun 54
Ives Jeffrey L.0001209191-23-034327
SEC(opens sec.gov)
Jul 194
Ives Jeffrey L.0001209191-22-042606
SEC(opens sec.gov)
Jun 174
Ives Jeffrey L.0001209191-22-037881
SEC(opens sec.gov)
Jun 64
Ives Jeffrey L.0001209191-22-034626
SEC(opens sec.gov)

Companies

Address

C/O ACUMEN PHARMACEUTICALS, INC. 1210-1220 WASHINGTON STREET, SUITE 210

NEWTON, MA, 02465